Idelalisib for Relapsed Follicular Lymphoma (FL) and Small Lymphocytic Leukemia (SLL) Voluntarily Withdrawn from US Market
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Join us online for our next Chronic Lymphocytic Leukemia webinar where experts discuss CLL information highly relevant to patients, caregivers and advocates right now. Participants will have the opportunity to submit questions to be answered live by our expert panel. Topics for discussion include:
- Treatment Options: Duration
- Treatment Options: Oral agents and drug adherence
- Patient-Physician Conversations: How to decide treatment
- Psychosocial: stress, anxiety between treatments/tests
Register now for access to CURE®’s community of leukemia and lymphoma experts.
Please see additional information and registration here.
Related posts
